臨床診断市場は予測期間中に6.6％のCAGRで成長し1,355億ドルに達すると予想されます。その要因としては、不健康な習慣によるライフスタイルの変化によって、高血圧、糖尿病、心血管疾患などを発症するリスクが高まります。デジタル参加の増加により、消費者は臨床結果に関与できるようになり、運用コストが大幅に削減され、予測期間中の市場の成長を促進すると予想されます。非侵襲的出生前検査の受容製の高まりにより、革新的なナノマテリアルやポイントオブケア医療診断の導入が注目を集め、市場成長のための需要を促進すると予想されています。
目次
1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Clinical Diagnostics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Clinical Diagnostics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Clinical Diagnostics Market - Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Clinical Diagnostics Market
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Clinical Diagnostics Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test
11.3.1.1. Liver Panel
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Lipid Panel
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Renal Panel
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Electrolyte Testing
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Complete Blood Count
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6.Infectious Disease Testing
11.3.1.6.1.By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7.Others
11.3.1.7.1.By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Product
11.3.2.1.Reagents
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Instruments
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By End User
11.3.3.1.Diagnostic Laboratory
11.3.3.1.1.By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Hospital Laboratory
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2.Market Share (%) 2022-2032F
11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Point-of-care Testing
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2.Market Share (%) 2022-2032F
11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test
12.3.2.By Product
12.3.3.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test
13.3.2.By Product
13.3.3.By End User
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test
14.3.2.By Product
14.3.3.By End User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test
15.3.2.By Product
15.3.3.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Test
16.3.2.By Product
16.3.3.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.BioMerieux
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. ARUP Laboratories
18.3. Becton, Dickinson, and Company
18.4.Abbott Laboratories
18.5. Qiagen
18.6. Bio-Reference Laboratories
18.7. Labcorp
18.8.Bioscientia Healthcare
18.9. Danaher Corporation
18.10.Quest Diagnostics Inc.
18.11.Hologic Inc.
18.12.F. Hoffmann-La Roche AG
18.13.Thermo Fisher Scientific
18.14.Sonic Healthcare Ltd
18.15.Sysmex Corporation
18.16. Siemens AG
18.17. Other Prominent Players
19. Appendix
20.Consultant Recommendation
1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Clinical Diagnostics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Clinical Diagnostics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Clinical Diagnostics Market - Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Clinical Diagnostics Market
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Clinical Diagnostics Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test
11.3.1.1. Liver Panel
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Lipid Panel
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Renal Panel
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Electrolyte Testing
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Complete Blood Count
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6.Infectious Disease Testing
11.3.1.6.1.By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7.Others
11.3.1.7.1.By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Product
11.3.2.1.Reagents
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Instruments
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By End User
11.3.3.1.Diagnostic Laboratory
11.3.3.1.1.By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Hospital Laboratory
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2.Market Share (%) 2022-2032F
11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Point-of-care Testing
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2.Market Share (%) 2022-2032F
11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test
12.3.2.By Product
12.3.3.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test
13.3.2.By Product
13.3.3.By End User
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test
14.3.2.By Product
14.3.3.By End User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test
15.3.2.By Product
15.3.3.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Test
16.3.2.By Product
16.3.3.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.BioMerieux
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. ARUP Laboratories
18.3. Becton, Dickinson, and Company
18.4.Abbott Laboratories
18.5. Qiagen
18.6. Bio-Reference Laboratories
18.7. Labcorp
18.8.Bioscientia Healthcare
18.9. Danaher Corporation
18.10.Quest Diagnostics Inc.
18.11.Hologic Inc.
18.12.F. Hoffmann-La Roche AG
18.13.Thermo Fisher Scientific
18.14.Sonic Healthcare Ltd
18.15.Sysmex Corporation
18.16. Siemens AG
18.17. Other Prominent Players
19. Appendix
20.Consultant Recommendation
